Proactive Cancer Immunotherapies for Initial and Recurrent Disease

Institute for Systems Biology

This proposed program initially formalizes early detection strategies through deep characterizations of patients with ovarian, breast, and colorectal cancers, prior to selecting a set of cancer patients for clinical trial designed to intercept recurrent disease through the design and administration of personalized, tumor-specific vaccines.

Read More
Kiana McKenna